Harmony Biosciences Holdings (HRMY)

Currency in USD
34.67
-0.27(-0.77%)
Closed·
After Hours
34.670.00(0.00%)
·

HRMY Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
0.92 / 0.72
Revenue / Forecast
200.50M / 204.59M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/0.799--/218.73M----Free Sign Up
06/20250.92/0.72200.5M/204.59M+27.78%-2%Free Sign Up
03/20250.78/0.61184.73M/184.26M+27.87%+0.26%Free Sign Up
12/20241.08/0.69201.3M/198.6M+56.52%+1.36%Free Sign Up
09/20240.79/0.67186.04M/186.01M+17.91%+0.02%Free Sign Up
06/20241.05/0.01172.8M/173.24M+10,400%-0.25%Free Sign Up
03/20240.88/0.63154.6M/155.37M+39.68%-0.5%Free Sign Up
12/20230.73/0.72168.4M/169.65M+1.39%-0.74%Free Sign Up
09/20230.97/0.67160.3M/147.83M+44.78%+8.44%Free Sign Up
06/20230.76/0.61134.2M/142.02M+24.59%-5.51%Free Sign Up

All numbers in USD

Harmony Biosciences Holdings Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $0.92 beat expectations by 27.78%, but revenue of $200.5M missed forecasts; stock fell 3.88% pre-market
  • Revenue grew 16% YoY; company maintains strong cash position of $672M and generated $79M from operations in Q2
  • Wakix patient base increased by 400; full-year revenue guidance reaffirmed at $820M-$860M
  • Key catalysts ahead: ZYN-two Phase III data for Fragile X syndrome, initiation of Pitolacin HD Phase III trials
  • CEO emphasized profitability and self-funding status; company targets potential peak sales of $3-6B
Last Updated: 05/08/2025, 18:24
Read Full Transcript

FAQ

What Is Harmony Bio's Earnings Per Share (TTM)?

The Harmony Bio EPS (TTM) is 3.16.

When Is The Next Harmony Bio Earnings Date?

Harmony Bio will release its next earnings report on 03 Nov 2025.

What Is Harmony Bio’s Revenue Forecasts For Upcoming Quarters?

Harmony Bio’s revenue forecast is 218.73M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.